We recently hosted RM2030, the International Congress on Innovations in Reproductive Medicine, at CaixaForum València together with IVF-Worldwide. Over two days, we welcomed researchers, clinicians, and industry partners from Europe, North America, Latin America, the Middle East, and Australia, reinforcing Valencia’s role as a leading meeting point for innovation in reproductive health.
More than 40 international speakers presented new findings on gamete and embryo assessment, advanced imaging, endometrial biology, early-implantation models, and the integration of artificial intelligence in IVF laboratories. The program also included sessions focused on scientific reproducibility, study design, and methodological quality in biomedical research.
This year’s edition featured the Femtech Pitch Showcase & Competition, where nine emerging companies presented solutions in fertility, early diagnosis, and digital tools for reproductive health. The RM2030 Femtech Award was granted to U-Ploid Biotechnologies for its molecular engineering approach to improving oocyte quality in women of advanced reproductive age.
Scientific contributions covered advances in automated embryo transfer through the Transfer Direct System; new organoid- and blastoid-based models to study implantation; and multiomic research that redefines the role of the endometrium in conditions such as preeclampsia. Emerging screening strategies based on cell-free RNA and the growing impact of artificial intelligence on peer review and evidence interpretation were also discussed.
At the Carlos Simon Foundation, we are grateful for the strong engagement of all participants and for the high scientific level of this year’s meeting. RM2030 continues to grow as a collaborative forum where research, clinical practice, and technology converge to shape the future of reproductive medicine.